Trials / Completed
CompletedNCT02517424
Evaluating Safety and Efficacy of Cannabis in Participants With Chronic Posttraumatic Stress Disorder
Placebo-Controlled, Triple-Blind, Crossover Study of the Safety and Efficacy of Three Different Potencies of Vaporized Cannabis in 42 Participants With Chronic, Treatment-Resistant Posttraumatic Stress Disorder (PTSD)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Tilray · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of vaporized cannabis in participants with chronic, treatment-resistant posttraumatic stress disorder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | High THC/Low CBD Cannabis | Dried cannabis |
| DRUG | High THC/High CBD Cannabis | Dried cannabis |
| DRUG | Low THC/Low CBD Cannabis | Dried cannabis |
Timeline
- Start date
- 2017-02-07
- Primary completion
- 2019-03-22
- Completion
- 2019-03-22
- First posted
- 2015-08-07
- Last updated
- 2020-03-23
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02517424. Inclusion in this directory is not an endorsement.